Back to Insider Trading View Full Company Profile

ZVRA

CRITICAL

ZEVRA THERAPEUTICS, INC.

CIK: 0001434647

Strong Sell (70% confidence)

Last activity: 5 days ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Net Income -$8.55M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
McFarlane Neil F.
President and CEO
0 2 -$979K
387,225 shares
$3.31M
Schafer Joshua
CCO
0 2 -$126K
62,278 shares
$572K
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
0 2 -$43K
29,590 shares
$272K
Quartel Adrian W
Chief Medical Officer
0 1 -$40K
9,723 shares
$86K
Thompson Rahsaan
Chief Legal & Compliance
0 1 -$36K
49,919 shares
$441K

Recent Transactions

SELL McFarlane Neil F. (President and CEO)

14,625 shares @ $8.56

$125K

Feb 9, 2026

Conviction: | View SEC Filing →
SELL Schafer Joshua (CCO)

10,500 shares @ $9.19

$97K

Feb 3, 2026

Conviction: | View SEC Filing →
SELL Sangiovanni Timothy J. (SVP, Finance & Corp Controller)

3,000 shares @ $9.18

$28K

Feb 3, 2026

Conviction: | View SEC Filing →
SELL McFarlane Neil F. (President and CEO)

91,000 shares @ $9.38

$853K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Quartel Adrian W (Chief Medical Officer)

4,533 shares @ $8.83

$40K

Jan 30, 2026

Conviction: | View SEC Filing →
SELL Thompson Rahsaan (Chief Legal & Compliance)

4,080 shares @ $8.83

$36K

Jan 30, 2026

Conviction: | View SEC Filing →
SELL Schafer Joshua (CCO)

3,375 shares @ $8.83

$30K

Jan 30, 2026

Conviction: | View SEC Filing →
SELL Sangiovanni Timothy J. (SVP, Finance & Corp Controller)

1,750 shares @ $8.82

$15K

Jan 30, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.